Eurofins Scientific SE (STU:ESF0)

Full Year 2024 Eurofins Scientific SE Earnings Call Transcript

Jan 30, 2025 / 02:00 PM GMT

Release Date Price: €52.24 (+4.27%)

Transcript

Key Points

Positve

Eurofins Scientific SE (ERFSF) reported a strong year with significant growth in revenues, averaging 9% per annum over the past five years.
The company has successfully increased its EBITDA and EPS at a faster rate than revenue growth, indicating improved profitability.
Eurofins has made substantial investments in digitalization and infrastructure, which are beginning to yield positive results.
The company has achieved a significant improvement in free cash flow, growing by 69% year-on-year, with a strong cash conversion rate of 56%.
Eurofins has maintained a stable net debt level and reduced financial leverage, indicating strong financial management.

Negative

The BioPharma segment experienced a 10% contraction in revenues, impacting overall organic growth.
Growth in the second half of 2024 was lower than the long-term average target, with challenges in certain markets like Agroscience and early-stage pharma activities.
The company faces ongoing challenges with underutilized CapEx and investments that have not yet provided full returns.
There is uncertainty regarding the timing of recovery in certain segments, such as BioPharma and Agroscience, which could affect future growth.
Eurofins' share buyback strategy may limit available capital for other investments, as management views buying back shares as the best current investment.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EUFI.PA - Eurofins Scientific SE
Full Year 2024 Eurofins Scientific SE Earnings Call
Jan 30, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, welcome and thank you for joining Eurofins fy 2024 results presentation.

Please note that this call is being recorded and will later be available for replay on the Eurofins Investor relations website. Throughout today's presentation, all participants will be in a listen-only mode. The presentation will be followed by a question and answer session. If you would like to ask a question, you may press star followed by one on your touchtone telephone to register for questions for operator assistance. Please press the star key followed by zero during this call. Eurofins management may make forward-looking statements including but not limited to statements with respect to outlook and the related

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.